Eli Lilly owned a pre-IPO stake in TRex Bio that was the equivalent of 23.9 percent of the biotech’s outstanding stock; that stake was set to decline to 16.8 percent of TRex Bio’s outstanding shares ...

Iambic Therapeutics (IAM Proposed), a biotech targeting breast cancer and lung cancer, unveiled the terms for its $150 million IPO early today and launched the deal for pricing next week. The company ...

TRex Bio (TRXB Proposed), an Eli Lilly-backed biotech, unveiled the terms for its $125 million IPO early today: 8.33 million shares at a price range of $14.00 to $16.00 to raise $124.95 million, if ...

We are a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on ...

We are a newly organized blank check company. We intend to focus our search for an acquisition target on companies involved in agentic AI, stablecoin payments and digital yield platforms. Norma Chu is ...

Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums), is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might ...

Accelevation Holdings (ACCV) priced its IPO at $18.00 – $2.00 below range – and sold 30 million shares – the number of shares in the prospectus – to raise $540 million on Tuesday night, Sept. 29, 2026 ...

Oura (OURA Proposed), the maker of the Oura Ring, the world’s smallest smart ring, postponed its $2.1 billion IPO “despite strong demand, due to uncertainty in the IPO market,” the company said early ...

Accelevation Holdings (ACCV Proposed) outlined the terms today for its $660 million IPO: 30 million shares at a price range of $20.00 to $24.00 to raise $660 million, if priced at the $22.00 mid-point ...

Anthropic is on track to launch its highly anticipated IPO – most likely in November, according to a story posted online by The New York Times late this afternoon (Friday, Sept. 18, 2026). That ...

Electra Therapeutics (ETRA) upsized its IPO at pricing to 23.33 million shares – up from 21.67 million shares in the prospectus – and priced the IPO at $15.00 – the mid-point of its $14.00-to-$16.00 ...

Orion180 Insurance Group (OIG Proposed) revealed the terms for its $320 million IPO early today – Wednesday, Sept. 9, 2026 – and launched the deal to price next week. This is the second big IPO to ...